Legacy Capital Group California, Inc. Novartis Ag Transaction History
Legacy Capital Group California, Inc.
- $301 Billion
- Q3 2024
A detailed history of Legacy Capital Group California, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 2,762 shares of NVS stock, worth $267,306. This represents 0.11% of its overall portfolio holdings.
Number of Shares
2,762
Previous 2,732
1.1%
Holding current value
$267,306
Previous $291 Million
9.23%
% of portfolio
0.11%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.18 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.16 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$783 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$676 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$558 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $208B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...